Five key transaction trends in consumer healthcare
22 February 2022
Five key transaction trends in consumer healthcare have been identified by Deborah Wilkes, founder and editor & publisher of OTCToolbox.
Industry News
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
Nestlé is not keen to expand beyond VMS category
Premium
21 February 2022
Nestlé has “low interest” in entering the broader consumer healthcare market, said chief executive officer Mark Schneider, as Nestlé Health Science reported double-digit sales growth on an organic basis in 2021.
Navamedic strikes Nordics agreement with Ipsen
Premium
21 February 2022
Norway’s Navamedic has struck a deal with France’s Ipsen Consumer Healthcare in the Nordic region and said its Consumer Health business had recorded sales up by almost a third in 2021.
Reckitt moves VMS brands from Nutrition to Health
Premium
21 February 2022
Reckitt is moving its vitamins, minerals and supplements (VMS) business out of its Nutrition division and into its Health division.
Organon gains Marvelon and Mercilon rights from Bayer
Premium
21 February 2022
Organon has acquired Marvelon and Mercilon from Bayer in China, including Hong Kong and Macau, and has agreed to purchase the brands in Vietnam. The daily contraceptive pills have OTC status in some countries covered by the deals.
Industry in brief | IFF, Nature’s Sunshine, PharmaSGP
18 February 2022
IFF is acquiring Health Wright Products, Nature’s Sunshine has created a sustainability role, and PharmaSGP has released financial results.
Adamed achieves world first with OTC tadalafil
Premium
16 February 2022
Adamed Pharma has achieved a world first in its home market of Poland by switching the erectile-dysfunction drug tadalafil from prescription to non-prescription status.
US Senate confirms Califf as next FDA commissioner
16 February 2022
The US Senate has voted to confirm Robert Califf as commissioner of the US Food and Drug Administration (FDA) for a second time. Califf was previously FDA commissioner from 2016-2017.
Unilever rules out big acquisitions after failed GSK bid
Premium
15 February 2022
Unilever has ruled out any big acquisitions in the foreseeable future following its failed bid for GlaxoSmithKline (GSK) Consumer Healthcare.
Consumer Healthcare grows by a tenth at GSK
Premium
15 February 2022
GlaxoSmithKline (GSK) is in “full countdown mode” to demerging its Consumer Healthcare business, according to chief executive officer Emma Walmsley, who was speaking as the business reported sales up by a tenth at constant exchange rates in the fourth quarter of 2021.